Annual Retained Earnings
-$308.82 M
-$69.05 M-28.80%
31 December 2023
Summary:
Armata Pharmaceuticals annual retained earnings is currently -$308.82 million, with the most recent change of -$69.05 million (-28.80%) on 31 December 2023. During the last 3 years, it has fallen by -$129.12 million (-71.85%). ARMP annual retained earnings is now -3220.63% below its all-time high of -$9.30 million, reached on 31 December 1993.ARMP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$330.33 M
-$5.48 M-1.69%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly retained earnings is currently -$330.33 million, with the most recent change of -$5.48 million (-1.69%) on 30 September 2024. Over the past year, it has dropped by -$41.36 million (-14.31%). ARMP quarterly retained earnings is now -3451.99% below its all-time high of -$9.30 million, reached on 31 December 1993.ARMP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.8% | -14.3% |
| 3 y3 years | -71.8% | -67.8% |
| 5 y5 years | +24.0% | -116.0% |
ARMP Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -71.8% | at low | -67.8% | +1.1% |
| 5 y | 5 years | -96.0% | +24.0% | -116.0% | +1.1% |
| alltime | all time | -3220.6% | +24.0% | -3452.0% | +19.4% |
Armata Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$330.33 M(+1.7%) |
| June 2024 | - | -$324.85 M(-2.7%) |
| Mar 2024 | - | -$333.84 M(+8.1%) |
| Dec 2023 | -$308.82 M(+28.8%) | -$308.82 M(+6.9%) |
| Sept 2023 | - | -$288.97 M(+12.1%) |
| June 2023 | - | -$257.81 M(+1.4%) |
| Mar 2023 | - | -$254.26 M(+6.0%) |
| Dec 2022 | -$239.77 M(+18.2%) | -$239.77 M(+4.5%) |
| Sept 2022 | - | -$229.46 M(+3.9%) |
| June 2022 | - | -$220.85 M(+4.4%) |
| Mar 2022 | - | -$211.63 M(+4.3%) |
| Dec 2021 | -$202.86 M(+12.9%) | -$202.86 M(+3.1%) |
| Sept 2021 | - | -$196.81 M(+2.8%) |
| June 2021 | - | -$191.39 M(+3.3%) |
| Mar 2021 | - | -$185.20 M(+3.1%) |
| Dec 2020 | -$179.70 M(+14.1%) | -$179.70 M(+3.8%) |
| Sept 2020 | - | -$173.08 M(+3.4%) |
| June 2020 | - | -$167.31 M(+2.9%) |
| Mar 2020 | - | -$162.60 M(+3.2%) |
| Dec 2019 | -$157.52 M(-61.2%) | -$157.52 M(+3.0%) |
| Sept 2019 | - | -$152.94 M(+4.8%) |
| June 2019 | - | -$145.98 M(-64.4%) |
| Mar 2019 | - | -$409.93 M(+0.9%) |
| Dec 2018 | -$406.32 M(+3.1%) | -$406.32 M(+1.1%) |
| Sept 2018 | - | -$402.00 M(+0.4%) |
| June 2018 | - | -$400.39 M(+0.8%) |
| Mar 2018 | - | -$397.34 M(+0.8%) |
| Dec 2017 | -$394.21 M(+3.4%) | -$394.21 M(+0.6%) |
| Sept 2017 | - | -$391.85 M(+0.2%) |
| June 2017 | - | -$391.07 M(+1.7%) |
| Mar 2017 | - | -$384.61 M(+0.9%) |
| Dec 2016 | -$381.36 M(+5.2%) | -$381.36 M(+2.6%) |
| Sept 2016 | - | -$371.86 M(+0.6%) |
| June 2016 | - | -$369.49 M(+1.1%) |
| Mar 2016 | - | -$365.63 M(+0.9%) |
| Dec 2015 | -$362.52 M(+0.1%) | -$362.52 M(+0.6%) |
| Sept 2015 | - | -$360.29 M(-1.5%) |
| June 2015 | - | -$365.73 M(-2.9%) |
| Mar 2015 | - | -$376.50 M(+4.0%) |
| Dec 2014 | -$362.01 M(-6.0%) | -$362.01 M(+1.9%) |
| Sept 2014 | - | -$355.31 M(-5.2%) |
| June 2014 | - | -$374.70 M(-5.1%) |
| Mar 2014 | - | -$394.83 M(+2.5%) |
| Dec 2013 | -$385.12 M(+20.1%) | -$385.12 M(+22.4%) |
| Dec 2012 | -$320.53 M(-0.1%) | - |
| Sept 2009 | - | -$314.68 M(-0.2%) |
| June 2009 | - | -$315.35 M(-2.3%) |
| Mar 2009 | - | -$322.66 M(+0.6%) |
| Dec 2008 | -$320.87 M(+6.9%) | -$320.87 M(+3.5%) |
| Sept 2008 | - | -$310.02 M(+0.9%) |
| June 2008 | - | -$307.36 M(+1.3%) |
| Mar 2008 | - | -$303.57 M(+1.1%) |
| Dec 2007 | -$300.15 M | -$300.15 M(+1.7%) |
| Sept 2007 | - | -$295.08 M(+1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2007 | - | -$292.05 M(+1.5%) |
| Mar 2007 | - | -$287.86 M(+1.4%) |
| Dec 2006 | -$284.03 M(+13.6%) | -$284.03 M(-0.3%) |
| Sept 2006 | - | -$284.83 M(+1.1%) |
| June 2006 | - | -$281.64 M(+11.0%) |
| Mar 2006 | - | -$253.77 M(+1.5%) |
| Dec 2005 | -$250.04 M(+8.3%) | -$250.04 M(+1.4%) |
| Sept 2005 | - | -$246.49 M(+2.4%) |
| June 2005 | - | -$240.81 M(+2.2%) |
| Mar 2005 | - | -$235.51 M(+2.0%) |
| Dec 2004 | -$230.84 M(+6.6%) | -$230.84 M(+1.0%) |
| Sept 2004 | - | -$228.61 M(+1.2%) |
| June 2004 | - | -$225.89 M(+2.0%) |
| Mar 2004 | - | -$221.44 M(+2.2%) |
| Dec 2003 | -$216.58 M(+7.4%) | -$216.58 M(+3.0%) |
| Sept 2003 | - | -$210.27 M(+0.4%) |
| June 2003 | - | -$209.49 M(+3.4%) |
| Mar 2003 | - | -$202.58 M(+0.4%) |
| Dec 2002 | -$201.75 M(+13.4%) | -$201.75 M(+3.1%) |
| Sept 2002 | - | -$195.66 M(+2.5%) |
| June 2002 | - | -$190.83 M(+3.5%) |
| Mar 2002 | - | -$184.39 M(+3.6%) |
| Dec 2001 | -$177.98 M(+18.0%) | -$177.98 M(+4.7%) |
| Sept 2001 | - | -$169.91 M(+4.3%) |
| June 2001 | - | -$162.92 M(+3.7%) |
| Mar 2001 | - | -$157.06 M(+4.1%) |
| Dec 2000 | -$150.81 M(+45.7%) | -$150.81 M(+8.6%) |
| Sept 2000 | - | -$138.91 M(+25.0%) |
| June 2000 | - | -$111.11 M(+4.0%) |
| Mar 2000 | - | -$106.81 M(+3.2%) |
| Dec 1999 | -$103.50 M(+35.3%) | -$103.50 M(+3.1%) |
| Sept 1999 | - | -$100.40 M(+18.0%) |
| June 1999 | - | -$85.10 M(+7.4%) |
| Mar 1999 | - | -$79.20 M(+3.5%) |
| Dec 1998 | -$76.50 M(+12.8%) | -$76.50 M(-2.0%) |
| Sept 1998 | - | -$78.10 M(+4.6%) |
| June 1998 | - | -$74.70 M(+4.3%) |
| Mar 1998 | - | -$71.60 M(+5.6%) |
| Dec 1997 | -$67.80 M(+26.5%) | -$67.80 M(+6.4%) |
| Sept 1997 | - | -$63.70 M(+4.6%) |
| June 1997 | - | -$60.90 M(+6.7%) |
| Mar 1997 | - | -$57.10 M(+6.5%) |
| Dec 1996 | -$53.60 M(+94.2%) | -$53.60 M(+6.3%) |
| Sept 1996 | - | -$50.40 M(+7.5%) |
| June 1996 | - | -$46.90 M(+53.8%) |
| Mar 1996 | - | -$30.50 M(+10.5%) |
| Dec 1995 | -$27.60 M(+55.1%) | -$27.60 M(+10.8%) |
| Sept 1995 | - | -$24.90 M(+9.7%) |
| June 1995 | - | -$22.70 M(+11.8%) |
| Mar 1995 | - | -$20.30 M(+14.0%) |
| Dec 1994 | -$17.80 M(+91.4%) | -$17.80 M(+14.8%) |
| Sept 1994 | - | -$15.50 M(+16.5%) |
| June 1994 | - | -$13.30 M(+43.0%) |
| Dec 1993 | -$9.30 M | -$9.30 M |
FAQ
- What is Armata Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual retained earnings year-on-year change?
- What is Armata Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly retained earnings year-on-year change?
What is Armata Pharmaceuticals annual retained earnings?
The current annual retained earnings of ARMP is -$308.82 M
What is the all time high annual retained earnings for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual retained earnings is -$9.30 M
What is Armata Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ARMP annual retained earnings has changed by -$69.05 M (-28.80%)
What is Armata Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ARMP is -$330.33 M
What is the all time high quarterly retained earnings for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly retained earnings is -$9.30 M
What is Armata Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ARMP quarterly retained earnings has changed by -$41.36 M (-14.31%)